About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Colorectal Cancer Clinical Trials in Ohio | 390 Studies

Clinical Trials Colorectal CancerOhio

Colorectal Cancer Clinical Trials in Ohio

Find 390 clinical trials for colorectal cancer near Ohio. Connect with research centers in your area.

All Colorectal Cancer trials nationwide All trials in Ohio

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 161-180 of 390 trials

Active not recruitingDuloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal CancerThis phase II/III trial studies the best dose of duloxetine and how well it works in preventing pain, tingling, and numbness (peripheral neuropathy) caused by treatment with…NCT04137107·Birmingham, Alabama and 792 others

Colorectal Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

UnknownPROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing SurgeryThe standard treatment for locally advanced rectal cancer involves chemotherapy and radiation, known as 5FUCMT, (the chemotherapy drugs 5-fluorouracil/capecitabine and radiation…NCT01515787·Birmingham, Alabama and 1072 others

CompletedYttrium Y 90 Resin Microspheres Data Collection in Unresectable Liver Cancer: the RESIN StudyThis research registry studies Yttrium Y 90 resin microspheres in collecting data from patients with liver cancer not capable of being removed by surgery (unresectable) for the…NCT02685631·Birmingham, Alabama and 41 others

TerminatedA Phase 1a/1b FIH Study of PY159 and in Combination With Pembrolizumab in Subjects With Advanced Solid TumorsThis is an open-label, multicenter, First-In-Human (FIH), Phase 1a/1b study of PY159 in subjects with locally advanced (unresectable) and/or metastatic solid tumors that are…NCT04682431·Los Angeles, California and 16 others

CompletedStudy of TAS-102 in Patients With Metastatic Colorectal Cancer Refractory to Standard ChemotherapiesThe purpose of this study is to compare the efficacy and safety of TAS-102 versus placebo in patients with refractory metastatic colorectal cancer.NCT01607957·Glendale, Arizona and 114 others

TerminatedA Study Comparing the Efficacy and Safety of Vanucizumab and FOLFOX With Bevacizumab and FOLFOX in Participants With Untreated Metastatic Colorectal CancerThis is a Phase 2 multicenter, randomized, parallel arms, double-blind study of vanucizumab to evaluate the efficacy and safety of vanucizumab in combination with oxaliplatin…NCT02141295·Birmingham, Alabama and 38 others

TerminatedA Trial of Perioperative CV301 Vaccination in Combination With Nivolumab and Systemic Chemotherapy for Metastatic CRCThis is a multi-center Phase II randomized study.NCT03547999·Duarte, California and 6 others

Active not recruitingEvaluation of the ctDNA LUNAR Test in an Average Patient Screening EpisodeThe ECLIPSE (Evaluation of the ctDNA LUNAR test in an Average Patient Screening Episode) study is a prospective, observational multi-site study without randomization.NCT04136002·Anniston, Alabama and 270 others

TerminatedMorphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)The purpose of this study is to evaluate whether therapy with MORAb-004 is effective and safe in the treatment of metastatic, colorectal cancer.NCT01507545·Alhambra, California and 66 others

CompletedA Study of CTX-009 in Adult Patients With Metastatic Colorectal CancerThis study is designed as an open-label, adaptive Simon Two-Stage study to evaluate the efficacy of CTX-009 in patients with metastatic colorectal cancer.NCT05513742·Hot Springs, Arkansas and 6 others

Active not recruitingColonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM)Colorectal cancer (CRC) is currently the second most common cause of cancer death in the United States, and one of the most preventable cancers.NCT01239082·Phoenix, Arizona and 45 others

CompletedAn Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)This pilot, non-interventional, observational, Web-based, prospective cohort study is designed to collect self-reported safety and effectiveness and genetic data from subjects…NCT01598597·Many Locations, Alabama and 49 others

TerminatedObservational Study of Sub-populations From Cologuard Post-Approval Study (2014-01)The primary endpoint is to obtain longitudinal information on four sub-populations from the Cologuard Post-Approval Study.NCT03705013·Glendale, Arizona and 19 others

CompletedRadiation Therapy Plus Chemotherapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the RectumRATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells.NCT00006366·Birmingham, Alabama and 234 others

CompletedBlood and Stool Sample Collection in Subjects Participating in Colorectal Cancer Screening: Act BoldThe primary objective of this study is to collect de-identified, clinically-characterized stool and whole blood specimens for use in developing and evaluating the performance of…NCT03821948·Tempe, Arizona and 39 others

Active not recruitingDurvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung CancerThis randomized phase II trial studies the side effects of durvalumab and tremelimumab and to see how well they work with or without high or low-dose radiation therapy in treating…NCT02888743·Phoenix, Arizona and 41 others

CompletedPsychosocial Adjustment After Radiation Therapy in Patients With CancerRATIONALE: Gathering information about psychological and social adjustment after radiation therapy in patients with cancer may help doctors plan the best treatment.NCT00905086·Cleveland, Ohio

CompletedGeneral Surgical Outcomes Quality Improvement Database (UH-SOCRATES)A database has been established to track the outcomes of all cases performed in the University Hospitals Department of Surgery in an effort to improve quality of surgical…NCT00622557·Cleveland, Ohio

CompletedA Study of a Personalized Neoantigen Cancer VaccineThe purpose of this study is to evaluate the safety, dose, immunogenicity and early clinical activity of GRT-C901 and GRT-R902, a personalized neoantigen cancer vaccine, in…NCT03639714·Phoenix, Arizona and 10 others

CompletedA Phase 2 Trial of ALIMTA (LY231514, Pemetrexed) Plus Oxaliplatin Administered Every 21 Days for First-Line Treatment of Patients With Advanced Colorectal Cancer.The purpose of this study is to assess the antitumor activity of ALIMTA plus Oxaliplatin combination therapy in patients with previously untreated advanced colorectal cancerNCT00034619·Huntsville, Alabama and 21 others

PreviousPage 9 of 20Next

Other Conditions in Ohio

Breast Cancer Lung Cancer Prostate Cancer Melanoma Leukemia Lymphoma